These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [No-invasive determination of liver fat with 1H-MR spectroscopy]. van Werven JR; Nederveen AJ; Stoker J Ned Tijdschr Geneeskd; 2011; 155():A2756. PubMed ID: 21418702 [TBL] [Abstract][Full Text] [Related]
8. Reproducibility of 3.0 Tesla magnetic resonance spectroscopy for measuring hepatic fat content. van Werven JR; Hoogduin JM; Nederveen AJ; van Vliet AA; Wajs E; Vandenberk P; Stroes ES; Stoker J J Magn Reson Imaging; 2009 Aug; 30(2):444-8. PubMed ID: 19629974 [TBL] [Abstract][Full Text] [Related]
9. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388 [TBL] [Abstract][Full Text] [Related]
10. Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy. Moreno-Torres A; Domingo P; Pujol J; Blanco-Vaca F; Arroyo JA; Sambeat MA Antivir Ther; 2007; 12(2):195-203. PubMed ID: 17503662 [TBL] [Abstract][Full Text] [Related]
11. [Determination of liver triglycerides by 1H MR spectroscopy]. Hájek M; Dezortová M; Wagnerová D; Voska L; Hejlová I; Trunecka P Cas Lek Cesk; 2011; 150(1):68-71. PubMed ID: 21404492 [TBL] [Abstract][Full Text] [Related]
12. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A; J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218 [TBL] [Abstract][Full Text] [Related]
13. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. Simonen P; Kotronen A; Hallikainen M; Sevastianova K; Makkonen J; Hakkarainen A; Lundbom N; Miettinen TA; Gylling H; Yki-Järvinen H J Hepatol; 2011 Jan; 54(1):153-9. PubMed ID: 20947198 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Lu H; Zeng L; Liang B; Shu X; Xie D Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871 [TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. Radetti G; Kleon W; Stuefer J; Pittschieler K Acta Paediatr; 2006 Jul; 95(7):833-7. PubMed ID: 16801180 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839 [TBL] [Abstract][Full Text] [Related]